600380 健康元
2024/06 - 中期
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入8,234,634-5.56%16,646,35017,142,75315,903,68813,521,606
减:营业总成本6,247,788-8.83%13,123,51613,784,93813,169,41310,900,820
    其中:营业成本3,021,126-7.71%6,298,4666,252,2655,716,2944,874,187
               财务费用(123,729)0.93%(404,841)(352,447)(92,895)(98,886)
               资产减值损失(82,185)172.39%(312,370)(142,628)(62,951)(80,787)
公允价值变动收益(19,576)-50.21%(25,420)(76,263)(23,506)10,218
投资收益35,345-37.83%79,47555,97371,881182,316
    其中:对联营企业和合营企业的投资收益23,799-46.91%72,79470,57810,28117,271
营业利润1,986,9191.48%3,506,5653,479,9362,983,0672,972,955
利润总额1,982,0291.53%3,465,5553,456,1052,952,3292,950,160
减:所得税费用285,814-11.97%614,536561,797339,480371,694
净利润1,696,2164.22%2,851,0192,894,3082,612,8492,578,466
减:非控股权益919,79113.26%1,408,2391,391,5311,284,3501,458,027
股东净利润776,424-4.78%1,442,7801,502,7771,328,4991,120,440

市场价值指针
每股收益 (元) *0.416-2.49%0.7580.7930.6860.575
每股派息 (元) *----0.1800.1800.1500.150
每股净资产 (元) *7.63711.33%7.3746.8026.1965.682
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容